Metabolomics and Psychiatric Disease: NextGen Frontiers in Pathophysiology & Treatment

Tuesday, April 11, 2017
Metabolomics and Psychiatric Disease: NextGen Frontiers in Pathophysiology & Treatment

In our April Meet the Scientist Webinar, Dr. Lisa Pan will discuss her ongoing case-control trial looking for metabolic abnormalities in adolescents and young adults with treatment-refractory depression, although the specific metabolites involved have differed among patients, researchers have found that at least 60 percent of the patients had a deficiency in neurotransmitter metabolism, compared with none of the controls.

Watch webinar recording:

Presentation

Presented by 
Lisa A. Pan, M.D.
Lisa A. Pan, M.D.
University of Pittsburgh School of Medicine

Assistant Professor of Psychiatry and Clinical and Translational Science

2012 Young Investigator

 
Moderated by
Jeffrey Borenstein, M.D.
Brain & Behavior Research Foundation
 

Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein also serves as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association.

Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.